CITIGROUP INC - BELLICUM PHARMACEUTICALS INC ownership

BELLICUM PHARMACEUTICALS INC's ticker is BLCM and the CUSIP is 079481107. A total of 78 filers reported holding BELLICUM PHARMACEUTICALS INC in Q1 2016. The put-call ratio across all filers is 9.52 and the average weighting 0.0%.

Quarter-by-quarter ownership
CITIGROUP INC ownership history of BELLICUM PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2019$6,000
+20.0%
4,5420.0%0.00%
Q3 2019$5,000
-86.1%
4,542
-78.4%
0.00%
Q2 2019$36,000
-14.3%
21,054
+66.7%
0.00%
Q1 2019$42,000
+13.5%
12,628
-1.2%
0.00%
Q4 2018$37,000
-53.8%
12,776
-1.2%
0.00%
Q3 2018$80,000
-63.8%
12,933
-56.8%
0.00%
Q2 2018$221,000
+187.0%
29,911
+154.2%
0.00%
Q1 2018$77,000
+3750.0%
11,768
+4972.4%
0.00%
Q4 2017$2,000
-85.7%
232
-80.9%
0.00%
Q3 2017$14,000
+600.0%
1,214
+578.2%
0.00%
Q2 2017$2,0000.0%179
+14.7%
0.00%
Q1 2017$2,000
-90.0%
156
-84.2%
0.00%
Q3 2016$20,000
-39.4%
988
-61.6%
0.00%
Q2 2016$33,000
-45.0%
2,575
-60.2%
0.00%
Q1 2016$60,000
-81.2%
6,467
-59.1%
0.00%
Q4 2015$320,000
+86.0%
15,812
+33.7%
0.00%
Q3 2015$172,000
-32.8%
11,827
-1.5%
0.00%
Q2 2015$256,000
-49.5%
12,012
-45.0%
0.00%
Q1 2015$507,00021,8410.00%
Other shareholders
BELLICUM PHARMACEUTICALS INC shareholders Q1 2016
NameSharesValueWeighting ↓
EMORY UNIVERSITY 95,215$1,297,0001.28%
Baker Brothers Advisors 4,865,647$66,270,0000.65%
Eventide Asset Management 250,000$3,405,0000.22%
MCDANIEL TERRY & CO 76,112$1,037,0000.22%
SUFFOLK CAPITAL MANAGEMENT LLC 82,538$1,124,0000.15%
QVT Financial LP 337,923$4,603,0000.14%
KENNEDY CAPITAL MANAGEMENT LLC 478,465$6,517,0000.11%
Vident Investment Advisory, LLC 47,157$642,0000.08%
Tekla Capital Management LLC 60,000$817,0000.04%
First Eagle Investment Management, LLC 775,254$10,559,0000.03%
View complete list of BELLICUM PHARMACEUTICALS INC shareholders